| Literature DB >> 31620481 |
Pardis Saeedi1, Raheleh Halabian1, Abbas Ali Imani Fooladi1.
Abstract
Multipotent mesenchymal stem cells (MSCs) have been considerably inspected as effective tool for cell-based therapy of inflammatory, immune-mediated, and degenerative diseases, attributed to their immunomodulatory, immunosuppressive, and regenerative potentials. In the present review, we focus on recent research findings of the clinical applications and therapeutic potential of this cell type, MSCs' mechanisms of therapy, strategies to improve their therapeutic potentials such as manipulations and preconditioning, and potential/unexpected risks which should be considered as a prerequisite step before clinical use. The potential risks would probably include undesirable immune responses, tumor formation and the transmission of incidental agents. Then, we also review some of the milestones in the field, briefly discuss challenges and highlight the new guideline suggested for future directions and perspectives. 2019 Stem Cell Investigation. All rights reserved.Entities:
Keywords: Mesenchymal stem cells (MSCs); genetic manipulation; potential risks; preconditioning
Year: 2019 PMID: 31620481 PMCID: PMC6789202 DOI: 10.21037/sci.2019.08.11
Source DB: PubMed Journal: Stem Cell Investig ISSN: 2306-9759